These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18309965)

  • 1. Safety of very tight blood glucose control in type 2 diabetes.
    Home P
    BMJ; 2008 Mar; 336(7642):458-9. PubMed ID: 18309965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of very tight glucose control in type 2 diabetes in question.
    Idris I
    Diabetes Obes Metab; 2008 May; 10(5):438. PubMed ID: 18431839
    [No Abstract]   [Full Text] [Related]  

  • 3. [Typ 2 diabetes: glucose centered therapy is obsolete].
    Reincke M; Seissler J
    MMW Fortschr Med; 2008 May; 150(18):26-7. PubMed ID: 18533604
    [No Abstract]   [Full Text] [Related]  

  • 4. Strict glycaemic control in diabetic patients with CKD or ESRD: beneficial or deadly?
    Schernthaner G; Ritz E; Schernthaner GH
    Nephrol Dial Transplant; 2010 Jul; 25(7):2044-7. PubMed ID: 20388630
    [No Abstract]   [Full Text] [Related]  

  • 5. [New drugs for control of blood glucose in type 2 diabetes: summary of the NICE guidelines].
    Adler AI; Shaw EJ; Stokes T; Ruiz F
    Praxis (Bern 1994); 2009 Oct; 98(20):1161-3. PubMed ID: 19809980
    [No Abstract]   [Full Text] [Related]  

  • 6. [Not Available].
    Stainforth-Dubois M; McDonald EG
    CMAJ; 2021 Sep; 193(36):E1438-E1441. PubMed ID: 34518350
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy and safety of glimepiride in the management of type 2 diabetes in Muslim patients during Ramadan.
    Glimepiride in Ramadan (GLIRA) Study Group
    Diabetes Care; 2005 Feb; 28(2):421-2. PubMed ID: 15677804
    [No Abstract]   [Full Text] [Related]  

  • 8. Intensified glucose control in type 2 diabetes--whose agenda?
    Yudkin JS; Richter B; Gale EA
    Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nateglinide].
    Notoya Y; Kikuchi M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():371-5. PubMed ID: 12387020
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypoglycemia--simply annoying or dangerous?].
    Kern W
    MMW Fortschr Med; 2016 Jun; 158(11):67-70. PubMed ID: 27271419
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin for intensifying diabetes treatment.
    Meneghini LF
    J Fam Pract; 2011 Sep; 60(9 Suppl):S21-8. PubMed ID: 21912774
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucoregulation in type 2 diabetes: the lower the better? Glycosylated HbA1c of 6.5% seems to be the limit.
    Jazet IM; Meinders AE
    Eur J Intern Med; 2009 May; 20(3):232-5. PubMed ID: 19393489
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment.
    Rodriguez-Gutierrez R; Lipska KJ; McCoy RG
    JAMA Intern Med; 2016 Mar; 176(3):300-1. PubMed ID: 26882223
    [No Abstract]   [Full Text] [Related]  

  • 15. [Insulin therapy in patients with type 2 diabetes].
    Siegmund T; Schumm-Draeger PM
    MMW Fortschr Med; 2008 May; 150(18):32-5; quiz 36. PubMed ID: 18533606
    [No Abstract]   [Full Text] [Related]  

  • 16. [Not Available].
    Zulewski H
    Ther Umsch; 2017; 74(8):411-416. PubMed ID: 29461143
    [No Abstract]   [Full Text] [Related]  

  • 17. Case study 1: exploring the pharmacologic agents for treatment of type 2 diabetes.
    Martin CL
    Diabetes Educ; 2007; 33 Suppl 1():6S-13S. PubMed ID: 17272803
    [No Abstract]   [Full Text] [Related]  

  • 18. [Control of diabetes mellitus].
    Daweke H
    Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437
    [No Abstract]   [Full Text] [Related]  

  • 19. [Oral antidiabetics: how you take the right choice].
    Siegmund T; Schumm-Draeger PM
    MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():46-51; quiz 52. PubMed ID: 22916425
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease and type 2 diabetes: Importance of glycemic control.
    Bloomgarden Z
    J Diabetes; 2017 Aug; 9(8):722-723. PubMed ID: 28513098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.